140 related articles for article (PubMed ID: 10947025)
1. Combined bupropion-levodopa-trazodone therapy of sleep-related eating and sleep disruption in two adults with chemical dependency.
Schenck CH; Mahowald MW
Sleep; 2000 Aug; 23(5):587-8. PubMed ID: 10947025
[No Abstract] [Full Text] [Related]
2. Bupropion-induced neck and shoulder pain.
Sansone RA; Sansone LA
Pharmacopsychiatry; 2009 Sep; 42(5):203-4. PubMed ID: 19724984
[No Abstract] [Full Text] [Related]
3. Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression.
Andrade C
J Clin Psychiatry; 2013 Feb; 74(2):e119-21. PubMed ID: 23473356
[No Abstract] [Full Text] [Related]
4. Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: dose-finding study with no concomitant use of hypnotic agent.
Mashiko H; Niwa S; Kumashiro H; Kaneko Y; Suzuki S; Numata Y; Horikoshi R; Watanabe Y
Psychiatry Clin Neurosci; 1999 Apr; 53(2):193-4. PubMed ID: 10459686
[TBL] [Abstract][Full Text] [Related]
5. Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.
Pae CU; Lim HK; Han C; Patkar AA; Steffens DC; Masand PS; Lee C
Expert Rev Neurother; 2007 Oct; 7(10):1251-63. PubMed ID: 17939764
[TBL] [Abstract][Full Text] [Related]
6. [Current treatment of depression and agitation in the elderly -- clinical use of trazodone].
Osváth P
Neuropsychopharmacol Hung; 2013 Sep; 15(3):147-55. PubMed ID: 24108179
[TBL] [Abstract][Full Text] [Related]
7. [Trazodone Contramid® in clinical practice: personalizing antidepressant intervention].
Fagiolini A; Amodeo G; Goracci A; Blardi P
Riv Psichiatr; 2016; 51(4):123-128. PubMed ID: 27727261
[TBL] [Abstract][Full Text] [Related]
8. Psychopharmacology of smoking cessation in patients with mental illness.
Selby P
J Psychiatry Neurosci; 2006 Sep; 31(5):360. PubMed ID: 16951737
[No Abstract] [Full Text] [Related]
9. Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode.
Schönfeldt-Lecuona C; Connemann BJ; Wolf RC; Braun M; Freudenmann RW
Pharmacopsychiatry; 2006 Jul; 39(4):152-4. PubMed ID: 16871471
[TBL] [Abstract][Full Text] [Related]
10. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
11. Balance control improves following replacement of paroxetine with venlafaxine and levodopa in a case of microvascular dementia.
McDonald J; Corbeil P; Pourcher E
Am J Geriatr Pharmacother; 2011 Apr; 9(2):133-7. PubMed ID: 21507731
[TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
Park YM; Lee HJ; Kang SG; Choo CS; Cho JH
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):380-1. PubMed ID: 19121360
[No Abstract] [Full Text] [Related]
13. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
Munizza C; Olivieri L; Di Loreto G; Dionisio P
Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
[TBL] [Abstract][Full Text] [Related]
14. Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.
Patterson F; Schnoll RA; Wileyto EP; Pinto A; Epstein LH; Shields PG; Hawk LW; Tyndale RF; Benowitz N; Lerman C
Clin Pharmacol Ther; 2008 Sep; 84(3):320-5. PubMed ID: 18388868
[No Abstract] [Full Text] [Related]
15. Perceptual disturbances associated with low-dose bupropion sustained-release treatment.
Liu CY; Chien YS
J Clin Psychopharmacol; 2007 Oct; 27(5):543-4. PubMed ID: 17873707
[No Abstract] [Full Text] [Related]
16. Effects of trazodone on night eating behavior: a case report.
Di Leone FG; Talevi D; Loriedo C
J Clin Psychopharmacol; 2015 Feb; 35(1):109-11. PubMed ID: 25478937
[No Abstract] [Full Text] [Related]
17. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
Leuchter AF; Cook IA; Gilmer WS; Marangell LB; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; Fava M; Iosifescu D; Greenwald S
Psychiatry Res; 2009 Sep; 169(2):132-8. PubMed ID: 19709754
[TBL] [Abstract][Full Text] [Related]
18. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
[TBL] [Abstract][Full Text] [Related]
19. Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.
Jamerson BD; Krishnan KR; Roberts J; Krishen A; Modell JG
Psychopharmacol Bull; 2003; 37(2):67-78. PubMed ID: 14566216
[TBL] [Abstract][Full Text] [Related]
20. A lasting change in trazodone response after non-convulsive electroshock therapy for medication-resistant senile depression.
Shen H; Awata S; Konno M; Sato M
Psychiatry Clin Neurosci; 1998 Feb; 52(1):111-3. PubMed ID: 9682943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
